Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1α and MCP-1 levels in type 2 diabetic patients

European Journal of Nutrition

Volumn 49, Issue 7, 2010, Pages 429-434

  Chao, Pei Chun ^a,b   Huang, Chien Ning ^b   Hsu, Cheng Chin ^a   Yin, Mei Chin ^c,d   Guo, Yu Ru ^c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

Dietary AGEs; Glycated LDL; IL 1 ; MCP 1

Indexed keywords

8 ISOPROSTANE; ADVANCED GLYCATION END PRODUCT; HEMOGLOBIN A1C; INTERLEUKIN 1ALPHA; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; FOOD COMPOSITION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DINOPROST; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; INTERLEUKIN-1ALPHA; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78049373400     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00394-010-0101-3     Document Type: Article

References (27)

1. T Koschinsky CJ He T Mitsuhashi R Bucala C Liu C Buenting K Heitmann H Vlassara 1997 Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy Proc Natl Acad Sci USA 94 6474 6479 1:CAS:528:DyaK2sXjvFGhu7g%3D 10.1073/pnas.94.12.6474 (Pubitemid 27270709)
2. S Riviere I Birlouez-Aragon B Vellas 1998 Plasma protein glycation in Alzheimer's disease Glycoconj J 15 1039 1042 1:CAS:528:DyaK1MXitlaktrk%3D 10.1023/A:1006902428776 (Pubitemid 29129203)
3. H Vlassara W Cai J Crandall T Goldberg R Oberstein V Dardaine M Peppa EJ Rayfield 2002 Inflammatory markers are induced by dietary glycotoxins: a major risk factor for diabetic angiopathy Proc Natl Acad Sci USA 99 15596 15601 1:CAS:528:DC%2BD3sXjvVyr 10.1073/pnas.242407999 (Pubitemid 35403978)
4. M Negrean A Stirban B Stratmann T Gawlowski T Horstmann C Götting K Kleesiek M Mueller-Roesel T Koschinsky J Uribarri H Vlassara D Tschoepe 2007 Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus Am J Clin Nutr 85 1236 1243 1:CAS:528:DC%2BD2sXls1Kiur4%3D
5. J Uribarri A Stirban D Sander W Cai M Negrean CE Buenting T Koschinsky H Vlassara 2007 Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects Diabetes Care 30 2579 2582 1:CAS:528:DC%2BD2sXht1CltrnM 10.2337/dc07-0320 (Pubitemid 47547799)
6. A Stirban M Negrean C Götting J Uribarri T Gawlowski B Stratmann K Kleesiek T Koschinsky H Vlassara D Tschoepe 2008 Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines Ann N Y Acad Sci 1126 276 279 1:CAS:528:DC%2BD1cXmtFyns7c%3D 10.1196/annals.1433.042 (Pubitemid 351589304)
7. HF Erbersdobler V Somoza 2007 Forty years of furosine-forty years of using Maillard reaction products as indicators of the nutritional quality of foods Mol Nutr Food Res 51 423 430 1:CAS:528:DC%2BD2sXltlagtbg%3D 10.1002/mnfr.200600154 (Pubitemid 47083651)
8. T Goldberg W Cai P Melpomeni V Dardaine BS Baliga J Uribarri H Vlassara 2004 Advanced glycoxidation end products in commonly consumed foods J Am Diet Ass 104 1287 1291 1:CAS:528:DC%2BD2cXntV2ktL4%3D 10.1016/j.jada.2004.05.214 (Pubitemid 39036519)
9. PC Chao CC Hsu MC Yin 2009 Analysis of glycative products in sauces and sauce-treated foods Food Chem 113 262 266 1:CAS:528:DC%2BD1cXhtF2ntb%2FO 10.1016/j.foodchem.2008.06.076
10. Department of Health (1998) Taiwan nutrient databases 1998. Department of Health, Executive Yuan, Taipei, Taiwan
11. J Shea E Randell S Vasdev PP Wang B Roebothan G Sun 2007 Serum retinol-binding protein 4 concentrations in response to short-term overfeeding in normal-weight, overweight, and obese men Am J Clin Nutr 86 1310 1315 1:CAS:528:DC%2BD2sXhtlWms7nE
12. CC Hsu CN Huang YC Hung MC Yin 2004 Five cysteine-containing compounds have antioxidative activity in Balb/cA mice J Nutr 134 149 152 1:CAS:528:DC%2BD2cXitlCksg%3D%3D
13. M Konishi M Iwasa J Araki Y Kobayashi A Katsuki Y Sumida N Nakagawa Y Kojima S Watanabe Y Adachi M Kaito 2006 Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane J Gastroenterol Hepatol 21 1821 1825 1:CAS:528:DC%2BD2sXkt1aqsQ%3D%3D 10.1111/j.1440-1746.2006.04420.x (Pubitemid 44657003)
14. T Miyata S Taneda R Kawai Y Ueda S Horiuchi M Hara K Maeda VM Monnier 1996 Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis Proc Natl Acad Sci USA 93 2353 2358 1:CAS:528:DyaK28XhvVSkt74%3D 10.1073/pnas.93.6.2353 (Pubitemid 26104354)
15. Y Wu V Monnier M Friedlander 1995 Reliable determination of furosine in human serum and dialysate proteins by high-performance liquid chromatography J Chromatogr B 667 328 332 1:CAS:528:DyaK2MXmsFGks7c%3D 10.1016/0378-4347(95) 00038-K
16. J Nourooz-Zadeh J Tajaddini-Sarmadi KL Ling SP Wolff 1996 Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma Biochem J 313 781 786 1:CAS:528:DyaK28XhtV2it70%3D
17. PB Duell JF Oram EL Biermann 1990 Nonenzymatic glycation of HDL resulting in inhibition of high-affinity binding to cultured human fibroblasts Diabetes 39 1257 1263 1:CAS:528:DyaK3MXhsVSrtL8%3D 10.2337/diabetes.39.10.1257
18. N Ahmed 2005 Advanced glycation endproducts-role in pathology of diabetic complications Diabetes Res Clin Pract 67 3 21 1:CAS:528:DC%2BD2cXhtFGhsb7I 10.1016/j.diabres.2004.09.004 (Pubitemid 40037725)
19. T Miyata Y Izuhara 2008 Inhibition of advanced glycation end products: an implicit goal in clinical medicine for the treatment of diabetic nephropathy? Ann N Y Acad Sci 1126 141 146 1:CAS:528:DC%2BD1cXmtFygurc%3D 10.1196/annals.1433.019 (Pubitemid 351589281)
20. JF Navarro-González FJ Milena C Mora C León J García 2006 Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotension-converting enzyme inhibition and pentoxifylline administration Am J Nephrol 26 562 570 10.1159/000098004 (Pubitemid 46143878)
21. N Demircan BG Safran M Soylu AA Ozcan S Sizmaz 2006 Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy Eye 20 1366 1369 1:CAS:528:DC%2BD28Xht12ktbjM 10.1038/sj.eye.6702138 (Pubitemid 44921137)
22. I Martinovic N Abegunewardene M Seul M Vosseler G Horstick M Buerke H Darius S Lindemann 2005 Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease Circulation J 69 1484 1489 1:CAS:528:DC%2BD2MXhtlamsLjP 10.1253/circj.69.1484 (Pubitemid 41743963)
23. RA Kreisberg 1998 Diabetic dyslipidemia Am J Cardiol 82 67 73 10.1016/S0002-9149(98)00848-0 (Pubitemid 29044484)
24. PE James D Lang T Tufnell-Barret AB Milsom MP Frenneaux 2004 Vasorelaxation by red blood cells and impairment in diabetes: reduced nitric oxide and oxygen delivery by glycated hemoglobin Circ Res 94 976 983 1:CAS:528:DC%2BD2cXivVKqsro%3D 10.1161/01.RES.0000122044.21787.01 (Pubitemid 38490076)
25. A Veiraiah 2005 Hyperglycemia, lipoprotein glycation and vascular disease Angiology 56 431 438 10.1177/000331970505600411 (Pubitemid 41040529)
26. K Isoda E Folco MR Marwali F Ohsuzu P Libby 2008 Glycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis Atherosclerosis 198 307 312 1:CAS:528: DC%2BD1cXmtlSqsLY%3D 10.1016/j.atherosclerosis.2007.10.035
27. R Cipriani M Sensi A Gabriele A Gatti E Mandosi U Di Mario S Morano 2004 The impairment of renal function is not associated to altered circulating vascular endothelial growth factor in patients with type 2 diabetes and hypertension Diabetes Nutr Metab 17 90 94 1:CAS:528:DC%2BD2cXmt1Cgt78%3D